Skip to main content

Advantages of Cellular Starting Material Characterization for Allogeneic Cell Therapy Applications

  

Discover how cellular starting material characterization can help optimize every stage of the cell therapy manufacturing process — from collection to infusion.

In this on-demand webinar, you'll learn how ACCELLIX™ brings automated cell phenotyping to the point of need, helping to save costs, reduce manual steps, and decrease testing workflow time by more than 80% compared to traditional flow cytometry. 

Advantages of Cellular Starting Material Characterization for Allogenic Cell Therapy Applications Image

Explore the Benefits of Fully Automated Flow Cytometry 

Complete the form below to access the webinar, which will be sent directly to your email after submission. By providing your information, you agree to receive additional emails from bioMérieux about cellular quality assessement.

To find out more about the management of your personal data and to exercise your rights, see our privacy policy.

  

You May Also Like...

Cell & Gene Therapy Solutions

Bring simplicity and automation to Cell & Gene Therapy manufacturing through advanced technologies that enhance quality, safety and efficiency; to achieve faster product release.

Learn More
Innovations Across the Cell Therapy Workflow Teaser

Innovations Across the Cell Therapy Workflow

Watch this panel discussion to explore innovations across the cell therapy workflow — from apheresis collection of cellular starting material, to its identification and characterization, and how data and insights are shared among stakeholders.

View Webinar
ACCELLIX™

ACCELLIX™

Stringent quality and process control is essential to monitor critical parameters, from cellular starting material collection through cell therapy manufacturing, and these laborious tests are challenging to standardize. The ACCELLIX™ Automated Cell Phenotyping Platform eliminates these limitations and automates your entire testing workflow, from sample preparation to data analysis, generating rapid cell phenotyping results directly in the collection site and/or manufacturing suite.

Learn More